A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Regeneron Study Site, Berlin

Regeneron Study Site, Berlin

Regeneron Study Site, Kew Gardens

Regeneron Study Site, Mineola

Regeneron Study Site, Mahlow

Regeneron Study Site, Washington D.C.

Regeneron Study Site, Rockville

Regeneron Study Site, Norfolk

Regeneron Study Site, Lübeck

Regeneron Study Site, Kiel

Regeneron Study Site, Morgantown

Regeneron Study Site, Winston-Salem

Regeneron Study Site, Sandy Springs

Regeneron Study Site, Macon

Regeneron Study Site, Birmingham

Regeneron Study Site, Columbus

Regeneron Study Site, Münster

Regeneron Study Site, Bonn

Regeneron Study Site, Milwaukee

Regeneron Study Site, Frankfurt am Main

Regeneron Study Site, St Louis

Regeneron Study Site, Saint Joseph

Regeneron Study Site, Houston

Regeneron Study Site, Augsburg

Regeneron Study Site, Langenau

Regeneron Study Site, Redwood City

Regeneron Study Site, Portland

Regeneron Study Site, Dresden

Regeneron Study Site, Gera

Regeneron Study Site, Kawasaki

Regeneron Study Site, Sakai

Regeneron Study Site, Shinjuku

Regeneron Study Site, Tachikawa

Regeneron Study Site, Kyoto

Regeneron Study Site, Osaka

Regeneron Study Site, Tokyo

Regeneron Study Site, Tokyo

Regeneron Study Site, Bialystok

Regeneron Study Site, Chorzów

Regeneron Study Site, Katowice

Regeneron Study Site, Katowice

Regeneron Study Site, Kielce

Regeneron Study Site, Ostrowiec Świętokrzyski

Regeneron Study Site, Warsaw

Regeneron Study Site, Warsaw

Regeneron Study Site, Warsaw

Regeneron Study Site, Wroclaw

Regeneron Study Site, Wroclaw